Light-driven activation of mitochondrial proton-motive force improves motor behaviors in a Drosophila model of Parkinson's disease. 2019

Yuzuru Imai, and Tsuyoshi Inoshita, and Hongrui Meng, and Kahori Shiba-Fukushima, and Kiyotaka Y Hara, and Naoya Sawamura, and Nobutaka Hattori
1Department of Research for Parkinson's Disease, Juntendo University Graduate School of Medicine, Tokyo, 113-8421 Japan.

Mitochondrial degeneration is considered one of the major causes of Parkinson's disease (PD). Improved mitochondrial functions are expected to be a promising therapeutic strategy for PD. In this study, we introduced a light-driven proton transporter, Delta-rhodopsin (dR), to Drosophila mitochondria, where the mitochondrial proton-motive force (Δp) and mitochondrial membrane potential are maintained in a light-dependent manner. The loss of the PD-associated mitochondrial gene CHCHD2 resulted in reduced ATP production, enhanced mitochondrial peroxide production and lower Ca2+-buffering activity in dopaminergic (DA) terminals in flies. These cellular defects were improved by the light-dependent activation of mitochondrion-targeted dR (mito-dR). Moreover, mito-dR reversed the pathology caused by the CHCHD2 deficiency to suppress α-synuclein aggregation, DA neuronal loss, and elevated lipid peroxidation in brain tissue, improving motor behaviors. This study suggests the enhancement of Δp by mito-dR as a therapeutic mechanism that ameliorates neurodegeneration by protecting mitochondrial functions.

UI MeSH Term Description Entries
D008027 Light That portion of the electromagnetic spectrum in the visible, ultraviolet, and infrared range. Light, Visible,Photoradiation,Radiation, Visible,Visible Radiation,Photoradiations,Radiations, Visible,Visible Light,Visible Radiations
D008928 Mitochondria Semiautonomous, self-reproducing organelles that occur in the cytoplasm of all cells of most, but not all, eukaryotes. Each mitochondrion is surrounded by a double limiting membrane. The inner membrane is highly invaginated, and its projections are called cristae. Mitochondria are the sites of the reactions of oxidative phosphorylation, which result in the formation of ATP. They contain distinctive RIBOSOMES, transfer RNAs (RNA, TRANSFER); AMINO ACYL T RNA SYNTHETASES; and elongation and termination factors. Mitochondria depend upon genes within the nucleus of the cells in which they reside for many essential messenger RNAs (RNA, MESSENGER). Mitochondria are believed to have arisen from aerobic bacteria that established a symbiotic relationship with primitive protoeukaryotes. (King & Stansfield, A Dictionary of Genetics, 4th ed) Mitochondrial Contraction,Mitochondrion,Contraction, Mitochondrial,Contractions, Mitochondrial,Mitochondrial Contractions
D008954 Models, Biological Theoretical representations that simulate the behavior or activity of biological processes or diseases. For disease models in living animals, DISEASE MODELS, ANIMAL is available. Biological models include the use of mathematical equations, computers, and other electronic equipment. Biological Model,Biological Models,Model, Biological,Models, Biologic,Biologic Model,Biologic Models,Model, Biologic
D009043 Motor Activity Body movements of a human or an animal as a behavioral phenomenon. Activities, Motor,Activity, Motor,Motor Activities
D010300 Parkinson Disease A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75) Idiopathic Parkinson Disease,Lewy Body Parkinson Disease,Paralysis Agitans,Primary Parkinsonism,Idiopathic Parkinson's Disease,Lewy Body Parkinson's Disease,Parkinson Disease, Idiopathic,Parkinson's Disease,Parkinson's Disease, Idiopathic,Parkinson's Disease, Lewy Body,Parkinsonism, Primary
D011522 Protons Stable elementary particles having the smallest known positive charge, found in the nuclei of all elements. The proton mass is less than that of a neutron. A proton is the nucleus of the light hydrogen atom, i.e., the hydrogen ion. Hydrogen Ions,Hydrogen Ion,Ion, Hydrogen,Ions, Hydrogen,Proton
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D004198 Disease Susceptibility A constitution or condition of the body which makes the tissues react in special ways to certain extrinsic stimuli and thus tends to make the individual more than usually susceptible to certain diseases. Diathesis,Susceptibility, Disease,Diatheses,Disease Susceptibilities,Susceptibilities, Disease
D004330 Drosophila A genus of small, two-winged flies containing approximately 900 described species. These organisms are the most extensively studied of all genera from the standpoint of genetics and cytology. Fruit Fly, Drosophila,Drosophila Fruit Flies,Drosophila Fruit Fly,Drosophilas,Flies, Drosophila Fruit,Fly, Drosophila Fruit,Fruit Flies, Drosophila
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

Yuzuru Imai, and Tsuyoshi Inoshita, and Hongrui Meng, and Kahori Shiba-Fukushima, and Kiyotaka Y Hara, and Naoya Sawamura, and Nobutaka Hattori
March 2020, Journal of neuroscience research,
Yuzuru Imai, and Tsuyoshi Inoshita, and Hongrui Meng, and Kahori Shiba-Fukushima, and Kiyotaka Y Hara, and Naoya Sawamura, and Nobutaka Hattori
September 1986, Biochimica et biophysica acta,
Yuzuru Imai, and Tsuyoshi Inoshita, and Hongrui Meng, and Kahori Shiba-Fukushima, and Kiyotaka Y Hara, and Naoya Sawamura, and Nobutaka Hattori
May 2005, Biochemical and biophysical research communications,
Yuzuru Imai, and Tsuyoshi Inoshita, and Hongrui Meng, and Kahori Shiba-Fukushima, and Kiyotaka Y Hara, and Naoya Sawamura, and Nobutaka Hattori
January 2022, Frontiers in microbiology,
Yuzuru Imai, and Tsuyoshi Inoshita, and Hongrui Meng, and Kahori Shiba-Fukushima, and Kiyotaka Y Hara, and Naoya Sawamura, and Nobutaka Hattori
January 1983, European journal of biochemistry,
Yuzuru Imai, and Tsuyoshi Inoshita, and Hongrui Meng, and Kahori Shiba-Fukushima, and Kiyotaka Y Hara, and Naoya Sawamura, and Nobutaka Hattori
January 2005, Current issues in molecular biology,
Yuzuru Imai, and Tsuyoshi Inoshita, and Hongrui Meng, and Kahori Shiba-Fukushima, and Kiyotaka Y Hara, and Naoya Sawamura, and Nobutaka Hattori
January 2012, Journal of bacteriology,
Yuzuru Imai, and Tsuyoshi Inoshita, and Hongrui Meng, and Kahori Shiba-Fukushima, and Kiyotaka Y Hara, and Naoya Sawamura, and Nobutaka Hattori
September 1989, The Journal of biological chemistry,
Yuzuru Imai, and Tsuyoshi Inoshita, and Hongrui Meng, and Kahori Shiba-Fukushima, and Kiyotaka Y Hara, and Naoya Sawamura, and Nobutaka Hattori
May 1983, The Journal of biological chemistry,
Yuzuru Imai, and Tsuyoshi Inoshita, and Hongrui Meng, and Kahori Shiba-Fukushima, and Kiyotaka Y Hara, and Naoya Sawamura, and Nobutaka Hattori
January 2013, Molecular microbiology,
Copied contents to your clipboard!